Homocysteine, stroke, and dementia.
Authors:
- Amos D. KorczynAKAmos D. Korczyn
- Endres MEMEndres M
- Ahmadi MAMAhmadi M
- Kruman IKIKruman I
- Biniszkiewicz DBDBiniszkiewicz D
- Meisel AMAMeisel A
- Gertz KGKGertz K
- Schroecksnadel KSKSchroecksnadel K
- Frick BFBFrick B
- Fuchs DFDFuchs D
- 1 October 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (10) , 2343-4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or StrokeCerebrovascular Diseases, 2002
- Homocysteine and Cognitive Decline in Healthy ElderlyDementia and Geriatric Cognitive Disorders, 2001
- Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and DesignNeuroepidemiology, 2001
- Hyperhomocysteinemia in dementiaJournal of Neural Transmission, 2000
- Broadsheet number 58: homocysteine and diseasePathology, 2000
- Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer DiseaseArchives of Neurology, 1998
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998